Literature DB >> 25516169

Comparative pharmacokinetics of three monoester-diterpenoid alkaloids after oral administration of Acontium carmichaeli extract and its compatibility with other herbal medicines in Sini Decoction to rats.

Hai Zhang1,2, Min Liu3, Wen Zhang1, Jun Chen1, Zhenyu Zhu2, Hong Cao4, Yifeng Chai2.   

Abstract

Sini decoction (SND) is an important traditional Chinese multiherbal formula, which is widely used to treat cardiovascular disease. Acontium carmichaeli (AC) is a leading herb in SND, whose main components are monoester-diterpenoid alkaloids (MDAs). The aim of this study is to compare the pharmacokinetics of three MDAs in rat plasma after oral administration of AC extract and its compatibility with other herbal medicines in SND. A sensitive, accurate and specific LC-MS/MS method was developed to determine the contents of three MDAs in rat plasma. Male Sprague-Dawley rats were randomly assigned to four groups: AC, AC + ZO, AC + GU and SND groups. There were significant differences in the pharmacokinetic parameters (Cmax, Tmax, t1/2, AUC(0-24), MRT and CL). Compared with the AC group, Cmax, AUC(0-24) and CL of three MDAs increased and t1/2 decreased in AC + ZO, AC + GU and SND groups. Little changed in the AC + GU group in comparison with AC + ZO group, which indicated that other ingredients in ZO may promote the absorption rate and accelerate excretion rate of MDAs. The results could be helpful for revealing the compatibility mechanism of Chinese multiherbal medicine and providing clinical medication guidance on AC and its compatibility with other herbal medicines in SND.
Copyright © 2014 John Wiley & Sons, Ltd.

Entities:  

Keywords:  Acontium carmichaeli; LC-MS/MS; Sini decoction; compatibility mechanism; monoester-diterpenoid alkaloid; pharmacokinetics

Mesh:

Substances:

Year:  2014        PMID: 25516169     DOI: 10.1002/bmc.3394

Source DB:  PubMed          Journal:  Biomed Chromatogr        ISSN: 0269-3879            Impact factor:   1.902


  5 in total

1.  Compatibility of Fuzi and Ginseng Significantly Increase the Exposure of Aconitines.

Authors:  Ze-Yan Chen; Xu-Ya Wei; Zi-Dong Qiu; Yun Huang; Ting Tan; Yu-Lin Feng; Juan Guo; Guang-Hong Cui; Lu-Qi Huang; Chang-Jiang-Sheng Lai
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

2.  Development and Application of an UHPLC-MS/MS Method for Comparative Pharmacokinetic Study of Eight Major Bioactive Components from Yin Chen Hao Tang in Normal and Acute Liver Injured Rats.

Authors:  Yun Wang; Xinrui Xing; Yan Cao; Liang Zhao; Sen Sun; Yang Chen; Yifeng Chai; Si Chen; Zhenyu Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2018-11-01       Impact factor: 2.629

3.  A Novel Modulator of the Renin-Angiotensin System, Benzoylaconitine, Attenuates Hypertension by Targeting ACE/ACE2 in Enhancing Vasodilation and Alleviating Vascular Inflammation.

Authors:  Qi-Qiang Zhang; Feng-Hua Chen; Fei Wang; Xue-Mei Di; Wei Li; Hai Zhang
Journal:  Front Pharmacol       Date:  2022-03-11       Impact factor: 5.810

4.  Drug target identification using network analysis: Taking active components in Sini decoction as an example.

Authors:  Si Chen; Hailong Jiang; Yan Cao; Yun Wang; Ziheng Hu; Zhenyu Zhu; Yifeng Chai
Journal:  Sci Rep       Date:  2016-04-20       Impact factor: 4.379

5.  Cardiovascular Disease Chemogenomics Knowledgebase-guided Target Identification and Drug Synergy Mechanism Study of an Herbal Formula.

Authors:  Hai Zhang; Shifan Ma; Zhiwei Feng; Dongyao Wang; Chengjian Li; Yan Cao; Xiaofei Chen; Aijun Liu; Zhenyu Zhu; Junping Zhang; Guoqing Zhang; Yifeng Chai; Lirong Wang; Xiang-Qun Xie
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.